X0306 4/A 2015-06-19 2015-06-22 0 0001410939 Ophthotech Corp. OPHT 0001277966 PATEL SAMIR CHANDRAKANT C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 19TH FLOOR NEW YORK NY 10119 1 1 0 0 President Common Stock 2015-06-19 4 M 0 88904 1.59 A 88904 D Common Stock 2015-06-19 4 M 0 68157 1.59 A 157061 D Common Stock 2015-06-19 4 M 0 7937 1.59 A 164998 D Common Stock 2015-06-19 4 M 0 37377 1.59 A 202375 D Common Stock 2015-06-19 4 M 0 42583 1.65 A 244958 D Common Stock 2015-06-19 4 M 0 3 1.65 A 244961 D Common Stock 2015-06-19 4 M 0 14331 13.22 A 259292 D Stock Option (Right To Buy) 1.59 2015-06-19 4 M 0 88904 0.00 D 2020-05-17 Common Stock 88904 0 D Stock Option (Right To Buy) 1.59 2015-06-19 4 M 0 68157 0.00 D 2020-05-17 Common Stock 68157 0 D Stock Option (Right To Buy) 1.59 2015-06-19 4 M 0 7937 0.00 D 2020-05-17 Common Stock 7937 0 D Stock Option (Right To Buy) 1.59 2015-06-19 4 M 0 37377 0.00 D 2020-05-17 Common Stock 37377 0 D Stock Option (Right To Buy) 1.65 2015-06-19 4 M 0 42583 0.00 D 2021-05-10 Common Stock 42583 0 D Stock Option (Right To Buy) 1.65 2015-06-19 4 M 0 3 0.00 D 2022-04-08 Common Stock 3 0 D Stock Option (Right To Buy) 13.22 2015-06-19 4 M 0 14331 0.00 D 2023-05-28 Common Stock 14331 14382 D This option was granted on May 18, 2010 and is currently exercisable for all shares underlying the option. This option was granted on May 18, 2010 and is currently exercisable for all shares underlying the option. This option was granted on May 18, 2010 and is currently exercisable for all shares underlying the option. This option was granted on May 18, 2010 and is currently exercisable for all shares underlying the option. This option was granted on May 11, 2011 and is currently exercisable for all shares underlying the option. This option was granted on April 9, 2012 and is currently exercisable for all shares underlying the option. This option was granted on May 29, 2013 and vests over four years, with 2.0833% of the original number of shares underlying the option vesting monthly from the date of grant. This amendment to the June 22, 2015 Form 4 of the Reporting Person is made solely to (i) correct a scrivener's error with respect to the total number of shares beneficially owned following the reported transactions in Table I and (ii) remove footnote number 1 applied to the transaction codes in Tables I and II, which had previously stated that the exercises reported herein were effected pursuant to a Rule 10b5-1 trading plan. This amendment restates the original Form 4 in its entirety, and except for the foregoing changes, no other changes were made to the original Form 4. /s/ Justin Vogel, as Attorney-in-Fact for Samir Patel 2015-06-23